Published on 16 April 2024
Description:
Astellas' Marci English on managing the menopause; Clinigen’s Lorna Pender on treating rare diseases; the science behind behaviour change
Categories:
Pharmaceutical Market Europe28 articles from this collection:
PME APRIL 2024
PME
Comment
COMMUNIQUÉ 2024
Contents
News - April 2024
6-7 - PME - Pharma Market Europe Pharmaceutical News
News - April 2024
Dermatology News - April 2024
DARWIN'S MEDICINE - Strategising fast and slow
12 - Pharma Market Europe Darwin’s medicine
POLICY AND PUBLIC HEALTH - The princess, the queen and the grandfather
MIKE DIXON - Thinking differently
INNOVATIVE IMPACT BLOG - Supercharged strategies: it’s time for pharma to get brave and bold
ALZHEIMER’S DISEASE - Current trends and the renaissance of Alzheimer’s drug development
WOMEN’S HEALTH - Women’s health – managing the menopause
MICROBIOME AND DISEASE - Is the gut microbiome the next frontier in medicine?
RARE DISEASES - Raising awareness, listening to patients, making a difference
ADVERTORIAL WILMINGTON - Budget burnout: avoiding the pitfalls of outdated engagement strategies
BEHAVIOUR CHANGE - Behavioural science – the route to healthcare salvation?
HAVAS LYNX - Uncovering the millennial mindset – why two thirds of HCPs feel misunderstood by pharma
AI AND HEALTHCARE - Data integration and the AI healthcare revolution
PATIENT VOICE - Achieving patient-guided drug development: putting the patient experience first
Appointments - April 2024
Appointments - April 2024
Appointments - April 2024
HEALTHCARE COMMS - April 2024
RECRUITMENT - April 2024
PHARMAROLE
FLYPHARMA EUROPE
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services